Introduction {#sec1-1}
============

On human mucous membranes, particularly in the gut, enterococci usually persist as harmless to useful colonizers. A pathological role for enterococci is well established for urinary tract infections \[[@ref1]\], in bacterial endocarditis \[[@ref2]\], or in cases of translocation into primarily sterile compartments \[[@ref3], [@ref4]\]. Prophylaxis with combinations of cephalosporins and metronidazole works well during surgical operations on the open gut \[[@ref5], [@ref6]\], although enterococci are not susceptible to these antibiotics. This is regarded as an argument for the low etiological relevance of enterococci in abdominal infections \[[@ref5]\]. In corpses, in contrast, enterococci spread readily throughout the body of the deceased after the breakdown of the gut--blood barrier \[[@ref7]\] and drive their decomposition. In line with a presumably low pathogenicity, death after enterococcal infections is mainly observed in immunocompromised patients \[[@ref8]\].

With respect to this overall low relevance of enterococci in deep-seated infections, this study was undertaken to determine their etiological relevance in bloodstream infections, which has not yet been satisfactorily assessed. Clinical and diagnostic features of *Enterococcus* spp.-associated bacteremia were assessed and compared with those of bacteremia due to *Staphylococcus aureus* (both methicillin-susceptible and -resistant) and *Escherichia coli*, both of which are well-established causative agents of sepsis \[[@ref12], [@ref13]\].

We have set up the working hypothesis that, unlike sepsis caused by established bacterial pathogens, enterococcal bacteremia is primarily encountered in two groups of patients: One is comparably healthy and suffers from transient bacteremia potentially associated with surgical procedures or inflamed mucous membranes. The other consists of pre-mortal patients with a disrupted gut-blood barrier allowing easy translocation of gut-inhabiting bacteria like enterococci from the gut into the bloodstream. To test this hypothesis, the following severity indicators were compared: automated ventilation, catecholamine requirement, and death of patients bacteremic for one of the three species. Identification of polymicrobial bacteremia was used as a criterion for translocation events in severely ill patients.

Methods {#sec1-2}
=======

The study was designed as a retrospective observational study and carried out at the University Hospital of Rostock, Germany, covering a study interval from 2007 to 2011.

All patient samples were collected and processed according to the instructions of the accredited (DIN EN ISO 15189) Institute for Medical Microbiology, Virology and Hygiene of the Rostock University Hospital. The resulting data were analyzed with the SwissLab software (version 2.12.2.008848; SwissLab Ltd., Berlin, Germany) of the laboratory.

Assessment of the frequency of enterococci in blood cultures at the study site {#sec2-1}
------------------------------------------------------------------------------

The data from the 20 most frequent species isolated from blood culture bottles (BacT/ALERT SA/SN/FA/FN/PF, bioMérieux, Nürtingen, Germany) at the Institute for Medical Microbiology, Virology and Hygiene were used for comparison. Data sets were extracted from the Swiss-Lab laboratory software and analyzed using the HyBase software version 6.1508.1 (Tieto Germany Ltd., Regensburg, Germany). Mean values were calculated from the data from the study interval.

Inclusion and exclusion criteria {#sec2-2}
--------------------------------

For a more refined analysis, data from patients of the University Hospital Rostock suffering from *Enterococcus* spp. and/or *E. coli* and/or *S. aureus* (methicillin-susceptible or -resistant) bacteremia in the years 2007 to 2011 were included in the study. In the following sections, data sets from *S. aureus* and *E. coli* were occasionally combined for statistical reasons and are then referred to as "nonenterococci". Each bacterial species was counted only once per patient and hospital admission to avoid analyzing copy strains.

Assessment of clinical data {#sec2-3}
---------------------------

Available clinical data were retrospectively assessed from the medical records of the included patients. The assessment was performed anonymously to ensure the patients' rights to privacy. As well as age, gender, and death of patients during the hospital stay, a total of 20 clinical and laboratory features per patient were assessed. The assessment comprised differentiation of pure and mixed bacterial culture; surgical interventions in general and abdominal surgery in particular; presence of wounds, urinary catheters, and stomata; body temperature; blood pressure according to Riva-Rocci (RR) \[[@ref14]\]; pulse rate; leukocyte count; C-reactive protein levels; procalcitonin levels; detection of leukocytes and bacteria in urine samples; need for treatment in intensive care units (ICUs); catecholamine administration or invasive ventilation at the ICU; the presence of bacterial isolates from bronchoalveolar lavage; sepsis as the main diagnosis; and administration of antibiotic therapy at the time of sample acquisition.

The results were adjusted to remarkable findings as depicted and defined in *[Table 2](#table002a){ref-type="table"}* from the Results section. All data were included in a SAS database, version 9.4 (SAS Institute Inc., Cary, NC, USA), which was also used for all statistical assessments as described below.

Comparison of the enterococcus group and the nonenterococcus group regarding hard endpoints {#sec2-4}
-------------------------------------------------------------------------------------------

Hard endpoints for patients with enterococcal or nonenterococcal bacteremia were defined as need for invasive ventilation, need for catecholamine administration, and death at any time point in the hospital stay after the diagnosis of bacteremia. The data from the enterococcus and the nonenterococcus groups were compared with the χ^2^ test.

Assessment of the enterococcus group and the nonenterococcus group for single species or mixed bacterial species in blood cultures {#sec2-5}
----------------------------------------------------------------------------------------------------------------------------------

In the first step, differences between the frequencies of mixed-species bacterial culture in the enterococcus group and the nonenterococcus group were assessed based on odds ratios. In the second step, the same calculation was repeated for deceased patients only.

Comparison of factors associated with survival and death for the enterococcus group and the nonenterococcus group {#sec2-6}
-----------------------------------------------------------------------------------------------------------------

To identify factors associated with death specifically due to enterococcal bacteremia, all recorded clinical features were analyzed for associations with survival and death in both the enterococcus group and the nonenterococcus group. Taken together, this assessment should discriminate whether dying patients from the enterococcus group were more severely affected than patients from the nonenterococcus group. Furthermore, it should distinguish the extent of differences in clinical illness between dying and surviving patients in the two bacteremic groups.

A logistic regression (model: binary logit; optimization: Fischer's scoring) was performed to indicate the impact of score parameters on the fatal outcome for patients with enterococcal and nonenterococcal bacteremia. Then, an adapted logistic regression (model: binary logit; optimization: Fischer's scoring) with stepwise elimination was added to indicate only significant variables and two-way interactions regarding fatal outcome for patients with enterococcal and nonenterococcal bacteremia. Significance was assessed by χ^2^ testing.

Comparison of factors associated with other hard end-points in the enterococcus group and the nonenterococcus group {#sec2-7}
-------------------------------------------------------------------------------------------------------------------

The initially chosen hard endpoint parameters of death, need for catecholamine administration, and need for invasive ventilation were analyzed for independence. After reciprocal dependence of the three parameters had been proven by crosstabs (data not shown), logistic regression (model: binary logit; optimization: Fischer's scoring) with stepwise elimination was performed to indicate only significant variables and two-way interactions regarding the composite outcome "need for catecholamines and need for invasive ventilation and fatal outcome" for patients with enterococcal and nonenterococcal bacteremia. Significance was assessed by χ^2^ testing.

Ethics statement {#sec2-8}
----------------

Ethical clearance for the study, including the anonymized retrospective assessment of patients' data from their medical records without informed consent of the patients, was approved by the ethics committee of the University Medicine Rostock (study registration number: A 2015--0078) in accordance with relevant guidelines and regulations.

Results {#sec1-3}
=======

Frequency of enterococci in blood cultures at the study site {#sec2-9}
------------------------------------------------------------

In the list of the 20 most frequently isolated species from blood cultures at the University Hospital Rostock during the study period *([Supplementary Material 1](#supp001){ref-type="table"}), Enterococcus faecium* was at position no. 6 and *Enterococcus faecalis* at position no. 8. Next to typical skin contaminants such as coagulase-negative staphylococci and *Propionibacterium* spp., *E. coli* and *S. aureus* were the two most frequently isolated species with probable or at least presumptive etiological relevance for severe deep-seated infections or sepsis *([Supplementary Material 1](#supp001){ref-type="table"})*.

Included and excluded patients and samples {#sec2-10}
------------------------------------------

During the study interval, 32,394 blood culture bottles were assessed at the University Medicine Rostock. Adjusted for samples from the same patient during the same hospital stay, there were 3992 patients with one or more positive blood cultures and 12,266 patients with negative blood cultures. The distribution of analyzed blood culture samples as assessed by the laboratory statistics is depicted in *[Table 1](#table001){ref-type="table"}*.

Over the 5-year-interval of the study, 267 patients with enterococci in blood cultures, comprising 121 *E. faecalis*, 141 *E. faecium*, 4 *E. avium*, 1 *E. casseliflavus*, 1 *E. cecorum*, and 6 not further characterized *Enterococcus* spp., and 661 patients with nonenterococci, comprising 375 *E. coli*, 219 methicillin-susceptible *S. aureus*, and 67 methicillin-resistant *S. aureus* (MRSA), respectively, were identified and included in the study *([Table 1](#table001){ref-type="table"})*. Each patient was counted only once per hospital stay, irrespective of the number of positive blood cultures or the time between them. As also detailed in *[Table 2](#table002a){ref-type="table"}*, the coverage of data assessment of the affected patients ranged between one-half and three-quarters of the total number of patients with bacteremia due to enterococci, *E. coli*, or *S. aureus*. The incompleteness is due to the fact that not all patient files were assessable for logistic reasons.

The mean age of patients with enterococcal bacteremia was 63.8 years; that of patients with nonenterococcal bacteremia was 65.5 years. Among the individuals with enterococcal bacteremia, 67% were male; among the ones with nonenterococcal bacteremia, 56% were male.

Assessment of clinical data {#sec2-11}
---------------------------

Clinical characteristics were compared for enterococcal and nonenterococcal bacteremia *([Table 2](#table002a){ref-type="table"})*, ensuring sufficiently high patient numbers for statistical assessments as described in the following.

Comparison of the enterococcus group and the nonenterococcus group regarding hard endpoints {#sec2-12}
-------------------------------------------------------------------------------------------

Considering the two endpoints, i.e., need for mechanical ventilation and need for catecholamines, the risk was considerably increased in patients with enterococcal bacteremia in comparison with patients with *E. coli* or *S. aureus* bacteremia. The risk of dying, however, was identical in both groups *([Table 3](#table003){ref-type="table"})*. There were no relevant differences between *E. faecium*- and *E. faecalis*-associated bacteremia.

Assessment of the enterococcus group and the nonenterococcus group for one or more bacterial species in blood cultures {#sec2-13}
----------------------------------------------------------------------------------------------------------------------

The presence of more than one bacterial species in the blood culture medium was significantly more frequent in patients with enterococcal bacteremia than in patients with bacteremia due to *E. coli* or *S. aureus*. If only deceased patients were analyzed, the significance of this difference disappeared *([Table 4](#table004){ref-type="table"})*. Again, there were no detectable differences between *E. faecalis* and *E. faecium*.

The species distribution of the bacteria accompanying enterococci, *E. coli*, and *S. aureus* in mixed species blood cultures showed an inconclusive pattern *([Supplementary Material 2](#supp002){ref-type="table"}).* The low numbers of observed isolates did not allow for statistical analysis. However, enterococci were more frequently associated with coagulase-negative staphylococci than *S. aureus* or *E. coli.*

Factors associated with survival or death of patients with enterococcal or nonenterococcal bacteremia {#sec2-14}
-----------------------------------------------------------------------------------------------------

Logistic regression *([Table 5](#table005){ref-type="table"})* and logistic regression with stepwise elimination of factors *([Supplementary Material 3](#supp003){ref-type="table"})* indicated that patients with bacteremia due to *E. coli* and *S. aureus* were more likely to die in case of tachycardia with a pulse rate ≥100/min, low blood pressure (RR) of \<100/60, and need for catecholamines. For enterococcal bacteremia, this association was not observed.

Comparison of factors associated with a combined endpoint comprising "need for invasive ventilation, need for catecholamines, and death " in patients with enterococcal or nonenterococcal bacteremia {#sec2-15}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

When analyzed in cross tables, the three endpoints "need for invasive ventilation, need for catecholamines, and death" showed reciprocal dependence (data not shown). Therefore, an additional analysis that regarded the three parameters as a single composite endpoint was performed. Specifically for patients with *E. coli* and *S. aureus* bacteremia, the presence of stomata and intravenous catheters was associated with an increased risk. Specifically for patients with enterococcal bacteremia, fever combined with the presence of stomata was the only identified risk factor. Associations of shock parameters were no longer observed *([Supplementary Material 4](#supp004){ref-type="table"})*.

Discussion {#sec1-4}
==========

The study was performed to address the predisposing factors for and etiological relevance of enterococci in blood culture. Bacteremia due to *E. coli* and *S. aureus*, a likely cause of sepsis \[[@ref12], [@ref13]\], was chosen as a reference for the comparison. As described for other European hospitals \[[@ref15], [@ref16]\], *E. faecium* quantitatively dominated in comparison to the therapeutically less problematic *E. faecalis.* This is in contrast to other regions such as Australia, where *E. faecalis* dominates \[[@ref17]\]. Based upon data from the German National Surveillance System, an annual incidence of about 30,000 nosocomial *E. faecium* infections has been calculated, comprising 13.2% vancomycin-resistant isolates \[[@ref18]\], demonstrating the importance of vancomycin-susceptible strains.

The study produced several main results. First of all, patients with enterococcal bacteremia are typically more severely ill than patients with typical causative agents of sepsis like *E. coli* and *S. aureus* in their bloodstream. In spite of a comparable risk of death, patients with enterococci more frequently need catecholamines and invasive ventilation. In addition, enterococcal bacteremia was more frequently associated with at least one additional bacterial species in the bloodstream. Finally, fatal sepsis due to *E. coli* and *S. aureus* is usually associated with shock symptoms such as tachycardia, hypotonia, and need for catecholamines, whereas this association was not identified for the enterococci. The synopsis of these results suggests that severely ill patients more frequently suffer from enterococcal bacteremia, while patients who are still able to show a systemic inflammatory reaction resulting in shock are more likely to die from sepsis due to *E. coli* and *S. aureus.*

Data on the risk for bacteremia with vancomycin-susceptible enterococci are still rare \[[@ref9]\]. In particular, comparisons with the features of infections due to nonenterococcal causes of sepsis are usually absent. Bacteremia due to enterococci is usually hospital acquired, with urinary tract infections, intra-abdominal infections, and infective endocarditis as the major sources \[[@ref10]\]. In India, the rate of enterococcal bacteremia has been estimated at 25.4 episodes per 1000 admissions in trauma patients \[[@ref19]\]. Preliminary recent data suggest increased mortality in cases of repeated detection of positive blood cultures with enterococci, in particular in case of prolonged bloodstream infections lasting more than 6 days \[[@ref20]\].

This study implies that enterococcal bacteremia and *E. coli* and *S. aureus* bacteremia display identical risks of dying, being 18.4% and 19.3% of the respective patients. This mortality matches that in a Polish study on enterococcal bacteremia, which indicated a 14-day mortality of 18.1% \[[@ref21]\]. In pediatric patients with enterococcal bacteremia after hematopoietic stem cell transplantation, a 30-day mortality of 20% has been reported irrespective of vancomycin susceptibility or resistance traits of the strains \[[@ref9]\]. In a Danish assessment, 30-day mortality of 21.4% due to *E. faecalis* and even of 34.6% due to *E. faecium* has been reported, with age, comorbidity, and hospital-acquired infections as predictors of deadly courses \[[@ref10]\]. Another analysis described a 7-day mortality of 13% and a 30-day mortality of 25% in patients with bacteremia due to vancomycin-susceptible enterococci \[[@ref8]\]. Prolonged healthcare exposure and increased comorbidity are associated with enterococcal bacteremia \[[@ref8], [@ref22]\]. The mortality risk in vancomycin-resistant enterococci (VRE) patients is generally higher \[[@ref23], [@ref24]\].

The patient numbers with 112 *E. faecalis* and 141 *E. faecium* bacteremic isolates did not allow for a statistically meaningful analysis. From the literature, it is known that invasive procedures, surgery, chronic skin ulcers, and indwelling devices are risk factors in particular for *E. faecalis* infections \[[@ref25]\]. Community-acquired bacteremia due to *E. faecalis* was shown to be associated with infective endocarditis in 25% of instances \[[@ref10]\]. For *E. faecium*, in contrast, it could be demonstrated that certain clones of increased pathogenic potential may cause invasive disease with bacteremia \[[@ref26]\]. In cancer patients, *E. faecium* bacteremia is independently associated with more severe underlying illness \[[@ref27], [@ref28]\].

Enterococci can lead to systemic infections if the gut-blood barrier fails and if the intestinal flora is disrupted by antibiotic treatment, resulting in domination of the gut flora by enterococcal species \[[@ref29]\]. The higher rate of mixed bacterial flora in patients with enterococcal bacteremia in this study could be due to a disturbed gut--blood barrier in severely ill patients. While 27.4% of mixed bacterial infections were observed in this study, a previous assessment suggested up to 39% bacteremia with enterococci plus other species \[[@ref10]\]. Interestingly, in this study, typically skin-inhabiting coagulase-negative staphylococci (CNS) predominated as partners in enterococcal bacteremia, while typical gut colonizers were less frequently observed. There is a formal possibility that CNS in blood cultures result from improper skin disinfection during specimen sampling \[[@ref30], [@ref31]\]. However, the legally enforced annual surveillance on infectious disease data of the Rostock University Hospital demonstrates CNS rates in blood cultures at or below the average of the hospitals in this region. In addition, CNS were more frequently associated with enterococcal but not with nonenterococcal bacteremias. Therefore, the occurrence of enterococci could be interpreted as a warning sign for critical disease courses with failing gut--blood barrier. However, risk of dying due to polymicrobial bacteremia is 21% \[[@ref32]\] and thus comparable with the general risk of dying as observed in this study.

The study has several limitations. First of all, the number of assessed samples does not allow for detailed sub-group analyses. Future studies with higher numbers of included patients should address the impact of immunosuppression of affected patients and the question whether comparable results can be achieved for patients with repeated proof of enterococci in blood culture. In addition, it would be interesting to compare healthcare-associated from community-acquired infections with enterococci, which was not analyzed by this approach.

Summary {#sec1-5}
=======

In summary, it was shown that patients with enterococcal bacteremia exhibit a risk of dying comparable to that for *E. coli* and *S. aureus* bacteremia and an even higher morbidity as expressed by need for catecholamines and invasive ventilation. Thus, patients dying with enterococcal bacteremia are usually more severely ill than patients with nonenterococcal bloodstream infections. Together with the lack of association between typical signs of shock and death due to enterococcal bacteremia, the low pathogenic potential of enterococci in the bloodstream has to be acknowledged when compared with bacteremia due to *E. coli* and *S. aureus.* Thus, in many cases, enterococcal bacteremia could rather be an epiphenomenon of impending death than one of its true causes. The higher frequency of mixed bacterial blood cultures indicating failure of the gut--blood barrier further supports this interpretation for patients with enterococcal bacteremia.
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###### 

Statistics of assessed blood culture samples during the study interval from 2007 to 2011 at the University Medicine Rostock

  Groups                                                                    2007--2011                                  2007   2008   2009   2010   2011
  ------------------------------------------------------------------------- ------------------------------------------- ------ ------ ------ ------ ------
  Assessed blood culture samples (total)                                    32394                                       6324   6165   6092   6924   6889
  Assessed blood culture samples (corrected by copy strains)                16258                                       3020   3078   3209   3433   3518
  Positive blood culture samples (total)                                    5640                                        1053   1134   1036   1177   1240
  Positive blood culture samples (corrected by copy strains)                3992                                        758    777    750    810    897
  Negative blood culture samples (total)                                    26754                                       5271   5031   5056   5747   5649
  Negative blood culture samples (corrected by copy strains)                12266                                       2262   2301   2459   2623   2621
  Detected enterococci (total)                                              567                                         133    98     92     140    104
  Detected enterococci (corrected by copy strains)                          369                                         88     66     63     86     66
  Included patients with enterococci into the assessment                    267^[\*](#tfn001){ref-type="table-fn"}^     48     40     30     49     41
  Detected *Enterococcus faecalis* (total)                                  221                                         48     34     46     55     38
  Detected *Enterococcus faecalis* (corrected by copy strains)              147                                         30     26     31     30     30
  Included patients with *Enterococcus faecalis* into the assessment        112^[\*\*](#tfn002){ref-type="table-fn"}^   17     18     16     13     22
  Detected *Enterococcus faecium* (total)                                   312                                         75     62     37     77     61
  Detected *Enterococcus faecium* (corrected by copy strains)               196                                         51     39     25     50     31
  Included patients with *Enterococcus faecium* into the assessment         141^[†](#tfn003){ref-type="table-fn"}^      29     22     11     35     16
  Detected *S. aureus* (including MRSA, total)                              650                                         84     135    126    165    140
  Detected *S. aureus* (including MRSA, corrected by copy strains)          363                                         51     77     70     84     81
  Included patients with *S. aureus* (including MRSA) into the assessment   286[‡](#tfn004){ref-type="table-fn"}        30     52     49     49     61
  Detected MSSA (total)                                                     434                                         49     84     98     107    96
  Detected MSSA (corrected by copy strains)                                 275                                         37     54     57     67     60
  Included patients with MSSA into the assessment                           219^[§](#tfn005){ref-type="table-fn"}^      21     35     38     35     44
  Detected MRSA (total)                                                     216                                         35     51     28     58     44
  Detected MRSA (corrected by copy strains)                                 88                                          14     23     13     17     21
  Included patients with MRSA into the assessment                           67^[¶](#tfn006){ref-type="table-fn"}^       9      17     11     4      17
  Detected *E. coli* (total)                                                659                                         105    132    119    135    168
  Detected *E. coli* (corrected by copy strains)                            463                                         75     91     87     87     123
  Included patients with *E. coli* into the assessment                      375^[\#](#tfn007){ref-type="table-fn"}^     42     57     54     46     94

^\*^Missing documentation of isolation year for 59 data sets

^\*\*^Missing documentation of isolation year for 26 data sets

^†^Missing documentation of isolation year for 28 data sets

^‡^Missing documentation of isolation year for 55 data sets

^§^Missing documentation of isolation year for 46 data sets

^¶^Missing documentation of isolation year for 9 data sets

^\#^Missing documentation of isolation year for 82 data sets

###### 

Characteristics of surviving and deceased patients with enterococcal or nonenterococcal bacteremia

                                                                 Enterococcal bacteremia   Nonenterococcal bacteremia                                          
  -------------------------------------------------------------- ------------------------- ---------------------------- ---- ---- ----- ----- ---- ----- ----- -----
  Differentiation of pure and mixed bacterial culture                                                                                                          
     Pure                                                        110                       69                           39   20   59    386   91   91    90    138
     Mixed                                                       49                        31                           10   80         36    9    10    10    
  Surgical interventions occurred                                                                                                                              
     Yes                                                         100                       64                           25   56   62    125   31   26    26    152
     No                                                          57                        36                           21   44         284   69   74    74    
  Abdominal surgery occurred                                                                                                                                   
     Yes                                                         46                        29                           12   25   62    42    12   12    12    142
     No                                                          111                       71                           36   75         388   88   89    88    
  Presence of wounds                                                                                                                                           
     Yes                                                         35                        23                           14   29   63    78    19   26    26    145
     No                                                          120                       77                           35   71         337   81   75    74    
  Presence of stomata                                                                                                                                          
     Yes                                                         61                        39                           20   41   61    54    13   21    21    143
     No                                                          96                        61                           29   59         363   87   80    79    
  Body temperature (°C)                                                                                                                                        
     ≥38.5                                                       70                        48                           12   28   75    229   56   46    46    156
     \<38.0                                                      29                        20                           23   50         70    17   32    32    
     38.0--38.4                                                  47                        32                           10   22         107   26   21    21    
  Registered blood pressure according to Riva-Rocci (RR, mmHg)                                                                                                 
     \< 100/60                                                   32                        22                           13   28   77    80    20   41    41    171
     100/60--120/80                                              104                       72                           32   70         248   63   54    55    
     \> 120/80                                                   8                         6                            1    2          63    16   4     4     
  Pulse rate                                                                                                                                                   
     ≥100/min                                                    47                        33                           18   39   188   127   32   47    47    170
     \<100/min                                                   95                        67                           28   61         265   68   52    53    
  Leukocyte count                                                                                                                                              
     ≥11.5 × 10^9^/1                                             74                        51                           28   64   79    219   55   57    59    164
     \<11.5 × 10^9^/1                                            70                        49                           16   36         181   45   40    41    
  C-reactive protein (CRP)                                                                                                                                     
     CRP ≥0.05 g/1                                               142                       99                           44   98   79    391   98   100   100   162
     CRP\<0.05 g/1                                               1                         1                            1    2          8     2    0     0     

###### 

Characteristics of surviving and deceased patients with enterococcal or nonenterococcal bacteremia

                                                           Enterococcal bacteremia   Nonenterococcal bacteremia                                        
  -------------------------------------------------------- ------------------------- ---------------------------- ---- ---- ----- ----- ---- ---- ---- -----
  Procalcitonin                                                                                                                                        
     ≥0.5 × 10^--5^g/1                                     26                        90                           18   95   219   70    89   33   97   548
     \<0.5 × 10^--5^ g/1                                   3                         10                           1    5          9     11   1    3    
  Presence of urinary catheters                                                                                                                        
     Yes                                                   152                       98                           48   98   63    359   85   96   97   142
     No                                                    3                         2                            1    2          61    15   3    3    
  Detection of leukocytes in urine                                                                                                                     
     Yes                                                   45                        48                           6    29   152   172   58   25   53   315
     No                                                    49                        52                           15   71         127   42   22   47   
  Detection of bacteria in urine samples                                                                                                               
     Yes                                                   33                        42                           7    30   165   146   57   30   64   357
     No                                                    46                        58                           16   70         111   43   17   36   
  Treatment on intensive care unit required                                                                                                            
     Yes                                                   103                       66                           36   77   63    125   30   64   63   148
     No                                                    54                        34                           11   23         287   70   37   37   
  Need for catecholamines                                                                                                                              
     Yes                                                   65                        42                           31   66   64    67    16   52   51   147
     No                                                    91                        58                           16   34         346   84   49   49   
  Need for invasive ventilation                                                                                                                        
     Yes                                                   60                        38                           30   64   63    46    11   36   36   145
     No                                                    97                        62                           17   36         369   89   65   64   
  Antibiotic therapy at time point of sample acquisition                                                                                               
     Yes                                                   100                       65                           41   85   64    173   42   71   71   146
     No                                                    55                        35                           7    5          242   58   29   29   
  Main diagnosis sepsis                                                                                                                                
     Yes                                                   18                        11                           10   20   61    159   38   30   30   141
     No                                                    139                       89                           39   80         260   62   71   70   
  Isolates from bronchoalveolar lavage                                                                                                                 
     Yes                                                   1                         3                            2    25   229   3     12   3    27   624
     No                                                    29                        97                           6    75         23    88   8    73   

###### 

Differences regarding catecholamine administration, requirement for automated ventilation, and fatal outcome for patients with enterococcal bacteremia vs. patients with *S. aureus* or *E. coli.* The results were confirmed by a forward modeled logistic regression model

  ------------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------- ------------ -------------------------- ----------
                                        No catecholamines^[\*](#tfn008){ref-type="table-fn"}^            Catecholamines^[\*](#tfn008){ref-type="table-fn"}^              Odds ratio   95% Confidence interval    *P*
  Enterococcal bacteremia               107                                                              96                                                              3.0          2.1--4.2                   \<0.0001
  Nonenterococcal bacteremia            397                                                              119                                                             Ref.                                    
                                        No catecholamines^[\*](#tfn008){ref-type="table-fn"}^            Catecholamines^[\*](#tfn008){ref-type="table-fn"}^              Odds ratio   95% Confidence interval    *p*
  Enterococcal bacteremia (other than   7                                                                2                                                               0.9          0.2--4.6                   0.95
  *E. faecalis* or *E. faecium)*                                                                                                                                                                                 
  Bacteremia due to *E. faecalis*       54                                                               31                                                              1.9          1.2--3.1                   0.01
  Bacteremia due to *E. faecium*        46                                                               63                                                              4.6          3.0--7.0                   \<0.0001
  Nonenterococcal bacteremia            397                                                              119                                                             Ref.                                    
                                        No automated ventilation^[\*\*](#tfn008){ref-type="table-fn"}^   Automated ventilation^[\*\*](#tfn008){ref-type="table-fn"}^     Odds ratio   95%) Confidence interval   *P*
  Enterococcal bacteremia               114                                                              90                                                              4.2          2\. 9--6.0                 \<0.0001
  Nonenterococcal bacteremia            434                                                              82                                                                                                      
                                        No automated ventilation^[\*\*](#tfn008){ref-type="table-fn"}^   Automated ventilation^[\*\*](#tfn008){ref-type="table-fn"}^ '   Odds ratio   95%o Confidence interval   *p*
  Enterococcal bacteremia (other than   8                                                                1                                                               0.7          0.1--5.4                   0.7
  *E. faecalis* or *E. faecium*)                                                                                                                                                                                 
  Bacteremia due to *E. faecalis*       58                                                               27                                                              2.5          1.5--4.1                   0.0006
  Bacteremia due to *E. faecium*        48                                                               62                                                              6.8          4.4--10.7                  \<0.0001
  Nonenterococcal bacteremia            434                                                              82                                                              Ref.                                    
                                        Survival^[†](#tfn008){ref-type="table-fn"}^                      Fatal outcome^[†](#tfn008){ref-type="table-fn"}^                Odds ratio   95%o Confidence interval   *P*
  Enterococcal bacteremia (other than   159                                                              49                                                              1.3          0.9--1.9                   0.2
  *E. faecalis* or *E. faecium*)                                                                                                                                                                                 
  Nonenterococcal bacteremia            422                                                              101                                                                                                     
                                        Survival^[†](#tfn008){ref-type="table-fn"}^                      Fatal outcome^[†](#tfn008){ref-type="table-fn"}^                Odds ratio   95% Confidence interval    *P*
  Enterococcal bacteremia (other than   7                                                                2                                                               1.2          0.2--5.8                   0.8
  *E. faecalis* or *E. faecium*)                                                                                                                                                                                 
  Bacteremia due to *E. faecalis*       67                                                               19                                                              1.1          0.7--2.1                   0.55
  Bacteremia due to *E. faecium*        85                                                               28                                                              1.4          0.8--2.2                   0.2
  Nonenterococcal bacteremia            422                                                              101                                                             Ref.                                    
  ------------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------- ------------ -------------------------- ----------

\*, \*\*, † Incomplete information for 21%, 23%o, and 22%o of data sets, respectively

###### 

Frequency of single and mixed bacterial species from patients with enterococcal bacteremia or patients with *S. aureus/E. coli* bacteremia with respect to the full sample size (upper table) and the subgroup of deceased patients (lower table)

  -------------------------------------------------------------------- ----------------------------------------------------- -------------------------------------------------- ------------ ------------------------- ----------
  All patients                                                                                                                                                                                                         
                                                                       2 or More species[\*](#tfn009){ref-type="table-fn"}   Single species[\*](#tfn009){ref-type="table-fn"}   Odds ratio   95% Confidence interval   *P*
  Enterococcal bacteremia                                              73                                                    194                                                3.8          2.6--5.6                  \<0.0001
  Nonenterococcal bacteremia                                           59                                                    600                                                Ref.                                   
  All patients                                                                                                                                                                                                         
                                                                       2 or More species[\*](#tfn009){ref-type="table-fn"}   Single species[\*](#tfn009){ref-type="table-fn"}   Odds ratio   95% Confidence interval   *P*
  Enterococcal bacteremia (other than *E. faecalis* or *E. faecium*)   6                                                     8                                                  7.63         2.6--22.7                 0.0003
  Bacteremia due to *E. faecalis*                                      29                                                    83                                                 3.6          2.2\--5.9                 \<0.0001
  Bacteremia due to *E. faecium*                                       38                                                    103                                                3.7          2.4\--5.9                 \<0.0001
  Nonenterococcal bacteremia                                           59                                                    600                                                Ref.                                   
  Deceased patients                                                                                                                                                                                                    
                                                                       2 or More species                                     Single species                                     Odds ratio   95% Confidence interval   *P*
  Enterococcal bacteremia                                              10                                                    39                                                 2.3          0.9\--6.0                 0.08
  Nonenterococcal bacteremia                                           10                                                    91                                                 Ref.                                   
  Deceased patients                                                                                                                                                                                                    
                                                                       2 or More species[\*](#tfn009){ref-type="table-fn"}   Single species[\*](#tfn009){ref-type="table-fn"}   Odds ratio   95% Confidence interval   *P*
  Enterococcal bacteremia (other than *E. faecalis* or *E. faecium*)   1                                                     1                                                  9.1          0.5\--156.9               0.13
  Bacteremia due to *E. faecalis*                                      4                                                     15                                                 2.4          0.7\--8.7                 0.17
  Bacteremia due to *E. faecium*                                       5                                                     23                                                 2.0          0.6\--6.3                 0.25
  Nonenterococcal bacteremia                                           10                                                    91                                                 Ref.                                   
  -------------------------------------------------------------------- ----------------------------------------------------- -------------------------------------------------- ------------ ------------------------- ----------

^\*^Incomplete data for 2 data sets each

###### 

Logistic regression (model: binary logit; optimization: Fischer's scoring) indicating the impact of score parameters on the fatal outcome for patients with enterococcal or nonenterococcal bacteremia. Significance was assessed by χ^2^ testing

  Odds ratio estimates and profile-likelihood confidence intervals[\*](#tfn010){ref-type="table-fn"}                                                                  
  ---------------------------------------------------------------------------------------------------- ------ -------------- -------- ---------- -------------------- --------
  Pure culture vs. mixed culture                                                                       1.30   0.49\--3.44    0.60     0.96       0.40\--2.30          0.92
  Surgery vs. no surgery                                                                               0.52   0.16\--1.66    0.27     0.34       0.16\--0.74          0.0063
  Any wounds vs. no wounds                                                                             0.91   0.36\--2.32    0.85     0.92       0.49\--1.76          0.81
  Any stomata vs. no stomata                                                                           0.85   0.29\--2.46    0.76     0.97       0.46\--2.04          0.94
  Abdominal surgery yes vs. no                                                                         1.19   0.43\--3.26    0.74     1.58       0.67\--3.73          0.30
  Temp. 38 °C\--38.4 °C versus temp. \<38 °C                                                           0.21   0.07\--0.64    0.0059   0.51       0.24\--1.12          0.09
  Temp. ≥38.5 °C vs. temp. \<38 °C                                                                     0.29   0.11\--0.82    0.019    0.66       0.33\--1.28          0.22
  Pulse rate ≥100/min vs. \<100/min                                                                    1.79   0.66\--4.82    0.25     2.04       1.17\--3.55          0.012
  Leukocytes ≥11.5 × 10^9^/1 vs.\<11.5 × 10^9^/1                                                       1.07   0.46\--2.53    0.87     1.10       0.63\--1.92          0.73
  CRP ≥0.05 g/1 vs. \<0.05 g/1                                                                         0.15   0.01\--3.06    0.22     \>999.99   \<0.01 to \>999.99   0.99
  Urinary catheter yes vs. no                                                                          0.79   0.06\--10.90   0.86     2.31       0.65\--8.16          0.20
  Need for intensive care treatment vs. no need                                                        0.24   0.04\--1.40    0.11     1.69       0.79\--3.61          0.18
  Need for catecholamines vs. no need                                                                  1.09   0.32\--3.78    0.89     2.38       1.04\--5.44          0.039
  Need for invasive ventilation yes vs. no                                                             9.35   1.99\--44.98   0.0047   2.05       0.81\--5.18          0.13
  Antibiotic therapy at time point of sample                                                           3.06   0.95\--9.91    0.06     2.57       1.46\--4.53          0.0011
  acquisition vs. no such therapy at this time point                                                                                                                  
  RR \<100/60 vs. RR 100/60\--120/80 (mmHg)                                                            1.16   0.43\--3.17    0.77     1.94       1.09\--3.44          0.024
  RR \>120/80 vs. RR 100/60\--120/80 (mmHg)                                                            1.41   0.13\--15.38   0.78     0.47       0.15\--1.47          0.19
  Main diagnosis sepsis vs. other than sepsis                                                          1.11   0.35\--3.54    0.86     0.46       0.25\--0.85          0.014

\*Detection of bacteria in bronchoalveolar lavage or urine samples as well as the parameters leukocytes in urine and elevated procalcitonin levels were excluded because of incomplete data sets

###### 

Most frequently isolated microbial species from blood cultures (total numbers of isolates without modifying algorithms of data assessment)

  Isolated microorganisms                             Mean number of isolates per year (averaged over 4 years)   Standard deviation (SD)
  --------------------------------------------------- ---------------------------------------------------------- -------------------------
  *Staphylococcus epidermidis*                        230                                                        20
  *Escherichia coli*                                  98                                                         18
  *Staphylococcus hominis*                            65                                                         16
  *Staphylococcus aureus* (methicillin susceptible)   62                                                         5
  *Propionibacterium* spp.                            40                                                         8
  *Enterococcus faecium*                              38                                                         13
  *Staphylococcus haemolyticus*                       34                                                         8
  *Enterococcus faecalis*                             30                                                         3
  *Staphylococcus aureus* (methicillin resistant)     20                                                         5
  *Staphylococcus capitis*                            19                                                         6
  *Candida albicans*                                  15                                                         5
  *Micrococcus* spp.                                  15                                                         4
  *Klebsiella pneumoniae*                             14                                                         4
  *Pseudomonas aeruginosa*                            12                                                         6
  *Streptococcus pneumoniae*                          11                                                         5
  *Proteus mirabilis*                                 10                                                         1
  *Enterobacter cloacae*                              9                                                          2
  *Streptococcus agalactiae*                          9                                                          4
  *Candida glabrata*                                  9                                                          6
  *Klebsiella oxytoca*                                8                                                          3

###### 

Distribution of the mixed detected flora by species or taxonomic group on enterococci, *E. coli*, and *S. aureus*

                                                       Enterococci   Staphylococcus aureus   Escherichia coli                  
  ---------------------------------------------------- ------------- ----------------------- ------------------ ---- ---- ---- ---
  Anaerobic bacteria                                   N             0                       0                  0    0    1    1
  \%                                                   0%            0%                      0%                 0%   0%   1%   
  Enterobacteriaceae                                   N             14                      4                  2    1    8    2
  \%                                                   2%            3%                      0%                 0%   0%   1%   
  Non-fermentative Gram-negative rod-shaped bacteria   N             5                       2                  1    0    4    0
  \%                                                   0%            1%                      0%                 0%   0%   0%   
  Other Gram-negative rod-shaped bacteria              N             1                       0                  0    0    1    0
  \%                                                   0%            0%                      0%                 0%   0%   0%   
  Enterococci as part of the mixed flora               N             2                       0                  0    0    0    0
  \%                                                   0%            0%                      0%                 0%   0%   0%   
  *Staphylococcus aureus* as part of the mixed flora   N             0                       0                  0    0    1    1
  \%                                                   0%            0%                      0%                 0%   0%   1%   
  Coagulase-negative staphylococci                     N             40                      2                  11   0    13   1
  \%                                                   4%            1%                      1%                 0%   1%   0%   
  *Streptococcus* spp.                                 N             3                       0                  2    1    5    1
  \%                                                   0%            0%                      0%                 0%   1%   1%   
  Other Gram-positive coccoid bacteria                 N             2                       0                  1    0    0    0
  \%                                                   0%            0%                      0%                 0%   0%   0%   
  Gram-positive rod-shaped bacteria                    N             2                       0                  2    0    2    1
  \%                                                   0%            0%                      0%                 0%   0%   1%   
  Fungi                                                N             5                       2                  1    0    1    1
  \%                                                   1%            1%                      0%                 0%   0%   1%   

###### 

Logistic regression (model: binary logit; optimization: Fischer's scoring) with stepwise elimination to indicate only significant variables and two-way-interactions regarding fatal outcome for patients with enterococcal or nonenterococcal bacteremia. Significance was assessed by chi-square testing

  Odds ratio estimates and profile-likelihood confidence intervals^[a](#tfn011){ref-type="table-fn"}^                                                   
  ----------------------------------------------------------------------------------------------------- ------ ------------ -------- ------ ----------- --------
  Any surgery vs. no surgery                                                                            0.33   0.12-0.83    0.02     0.36   0.20-0.63   \<0.01
  Temp. ≥38.5°C vs. temp. \<38°C                                                                        0.29   0.12-0.71    \<0.01   0.48   0.29-0.81   \<0.01
  Need for invasive ventilation yes vs. no                                                              4.98   2.03-13.51   \<0.01   2.53   1.30-5.04   \<0.01
  Temp. 38°C-38.5°C vs. temp. \<38°C                                                                    0.29   0.08-0.63    \<0.01   0.37   0.21-0.67   \<0.01
  Pulse rate ≥100 / min vs. \<100 / min                                                                                              1.82   1.16-2.86   \<0.01
  RR \<100/60 vs. RR 100/60-120/80 (mm Hg)                                                                                           1.82   1.14-2.89   0.01
  Need for catecholamines vs. no need                                                                                                2.06   1.16-3.64   0.01
  Antibiotic therapy at time point of sample acquisition vs. no such therapy at this time point                                      2.48   1.56-4.01   \<0.01

^a^Detection of bacteria in bronchoalveolar lavage or urine samples as well as the parameters leukocytes in urine and elevated procalcitonin levels were excluded because of incomplete data sets.

###### 

Logistic regression (model: binary logit; optimization: Fischer's scoring) with stepwise elimination to indicate only significant variables and two-way-interactions regarding the composite outcome need for catecholamines AND need for invasive ventilation AND fatal outcome for patients with enterococcal or nonenterococcal bacteremia. Reciprocal dependence of the three parameters of the composite outcome had been proven by crosstabs (data not shown). Significance was assessed by chi-square testing

  Odds ratio estimates and Wald confidence intervals^[a](#tfn012){ref-type="table-fn"}^                                                               
  ----------------------------------------------------------------------------------------------- ------- ------------ -------- ------- ------------- --------
  Intensive care unit vs. no-intensive care unit                                                  13.05   5.23-36.20   \<0.01   18.15   10.81-31.41   \<0.01
  Antibiotic therapy at time point of sample acquisition vs. no such therapy at this time point   3.08    1.27-7.71    \<0.01   2.80    1.65-4.85     \<0.01
  Temperature \>38.5°C with vs. without stomata                                                   6.75    2.02-22.58   \<0.01   \-      \-            \-
  Stomata vs. no stomata                                                                          \-      \-           \-       3.04    1.46-6.49     \<0.01
  Catheter vs. no catheter                                                                        \-      \-           \-       3.54    1.29-11.73    0.02

^a^Detection of bacteria in bronchoalveolar lavage or urine samples as well as the parameters leukocytes in urine and elevated procalcitonin levels were excluded because of incomplete data sets.
